Conference · San Francisco, California
Oncology Clinical Trials 2015
Biotechnology · Laboratory · Medicine
Key numbers
- Editions on record
- 5first in 2012
About Strategies for Clinical Oncology Drug Development
The recent breakthroughs in understanding the molecular biology of cancer have led to an unprecedented number of new targets in oncology drug development. There are more cancer drugs in the research pipeline than any other type of therapy, corresponding directly with the number of oncology clinical trials. Why do phase III clinical trials in oncology fail so often? One simple answer does not exist to this critically important question. Success of an oncology trial depends on many factors: scientific, organizational, biostatistical, regulatory, ethical and economical. The second annual Oncology Clinical Trials is designed to provide a comprehensive coverage of many of these components as well as present case studies of successful clinical trials.
From our listing of this edition. Details may have changed since.
Editions
| Year | Dates | Where | Exhibitors | Visitors |
|---|---|---|---|---|
| 2017 | 19–24 Feb 2017 | Moscone Convention Center San Francisco, California | — | — |
| 2015 | 13–15 Feb 2015 | Moscone Convention Center San Francisco, California | — | — |
| 2014 | 9–14 Feb 2014 | Moscone Convention Center San Francisco, California | — | — |
| 2013 | 13–15 Feb 2013 | Moscone Convention Center San Francisco, California | — | — |
| 2012 | 21 Feb – 23 Aug 2012 | Moscone Convention Center San Francisco, California | — | — |
Past editions from the bvents archive (2008–2019) and organiser figures where they were published.